Cysts by location
Female reproductive system
Nabothian cyst (on the surface of the cervix)
Ovarian cyst (ovary)
Paratubal cyst (in front of fallopian tube behind the ovary)
Vaginal cystsGartners duct cyst (lateral to vaginal wall)
Bartholins cyst (at vaginal introitus)
Skenes duct cyst (Beside the urinary meatus)
Ectopic ureterocoele (around the urinary meatus)
Urethral diverticulum (In front of vaginal wall)

Male reproductive system
Rete tubular ectasia (within the rete testis)
Epididymal cyst (in the epididymis)
Hydrocele testis (testicle): clear fluid within the cavum vaginale
Spermatocele (testicle): fluid within the head of epididymis

Cutaneous and subcutaneous
Acne cyst – Pseudocysts associated with cystic acne - an inflammatory nodule with or without an associated epidermoid inclusion cyst
Arachnoid cyst (between the surface of the brain and the cranial base or on the arachnoid membrane)
Epidermoid cyst
Myxoid cyst (cutaneous condition often characterized by nail plate depression and grooves)
Pilar cyst (cyst of the scalp)
Pilonidal cyst (skin infection near tailbone)
Sebaceous cyst – sac below skin
Trichilemmal cyst – same as a pilar cyst, a familial cyst of the scalp

Head and neck
Odontogenic cyst
Ceruminous cyst (ear)
Chalazion cyst (eyelid)
Mucous cyst of the oral mucosa
Nasolabial cyst
Thyroglossal cyst
Vocal fold cyst

Chest
Fibrous cyst (breast cyst)
Pulmonary cyst (air pocket in the lung)
Pericardial cyst (abnormal dilatation of pericardium)

Abdomen
Liver cysts
Simple cysts
Hydatid cysts
Biliary cystadenoma
Biliary cystadenocarcinoma
Polycystic liver disease
Adrenal cyst (glands located above the kidneys) - It is a rare disease, affecting 0.06 to 0.18% of autopsy studies. It constitutes 5.4 to 6.0% of adrenal gland diseases. There are five major types of adrenal cysts: simple or endothelial cysts, true or epithelial cysts, pseudocysts, parasitic cysts, and cysts not classified elsewhere. 7% of the cysts can be malignant.
In a 2016 report using both mouse models and a limited human clinical trial ROCK2 inhibition with belumosudil targeted both the immunologic and fibrotic components of cGvHD and reversed the symptoms of the disease.In October 2017, belumosudil was granted orphan drug status in the United States for treatment of patients with cGvHD.Efficacy of belumosudil was evaluated in clinical trial NCT03640481, a randomized, open-label, multicenter dose-ranging trial that included 65 patients with chronic GVHD who were treated with belumosudil 200 mg taken orally once daily.On 16 July 2021, the U.S. Food and Drug Administration (FDA) approved belumosudil for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy. Research
IPF is a progressive fibrotic disease where the lining of the lungs become thickened and scarred. Increased ROCK activity has been found in the lungs of humans and animals with IPF. Treatment with belumosudil reduced lung fibrosis in a bleomycin mouse model study.Psoriasis is an inflammatory skin condition where patients experiences eruptions and remissions of thickened, erythematous, and scaly patches of skin. Down-regulation of pro-inflammatory responses was observed with KD025 treatment in Phase 2 clinical studies in patients with moderate to severe psoriasis. References
External links
"Belumosudil". Drug Information Portal. U.S. National Library of Medicine.